International Stem Cell Co. (OTCMKTS:ISCO) Short Interest Update

International Stem Cell Co. (OTCMKTS:ISCO) saw a large increase in short interest in January. As of January 15th, there was short interest totalling 1,500 shares, an increase of 400.0% from the December 31st total of 300 shares. Based on an average trading volume of 22,400 shares, the days-to-cover ratio is currently 0.1 days.

International Stem Cell Stock Performance

International Stem Cell stock remained flat at $0.11 during mid-day trading on Thursday. The company’s fifty day moving average is $0.10 and its 200-day moving average is $0.08. International Stem Cell has a 52 week low of $0.05 and a 52 week high of $0.20.

International Stem Cell Company Profile

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.